First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 13, 2023

Primary Completion Date

April 15, 2024

Study Completion Date

April 23, 2024

Conditions

Voice Disorder Due to Iatrogenic Factor

Interventions

DRUG

Chlor-Trimeton.

Package dose of Chlor-Trimeton will be administered

Trial Locations (1)

Department of Speech, Language & Hearing Sciences, Auburn University, Auburn

All Listed Sponsors

lead

Auburn University

OTHER

NCT05858216 - First-generation OTC Antihistamine Use and Voice Function: A Preliminary Study | Biotech Hunter | Biotech Hunter